1. Recent Advances in the Pharmacotherapy of Infantile Spasms

   • Raili Riikonen

   Current Opinion 07 February 2014 Pages: 279 - 290

2. The Evidence for a Beneficial Role of Vitamin A in Multiple Sclerosis

   • Yara Dadalti Fragoso
   • Patrick N. Stoney
   • Peter J. McCaffery

   Leading Article 21 February 2014 Pages: 291 - 299

3. Psychopharmacological Treatment of Neurocognitive Deficits in People with Schizophrenia: A Review of Old and New Targets

   • Anthony O. Ahmed
   • Ishrat A. Bhat

   Review Article 14 February 2014 Pages: 301 - 318

4. The Mu-Opioid Receptor Agonist/Noradrenaline Reuptake Inhibition (MOR–NRI) Concept in Analgesia: The Case of Tapentadol

   • Thomas M. Tzschentke
   • Thomas Christoph
   • Babette Y. Kögel

   Review Article 28 February 2014 Pages: 319 - 329

   

5. Role of Lithium Augmentation in the Management of Major Depressive Disorder

   • Michael Bauer
   • Mazda Adli
   • Maximilian Pilhatsch

   Review Article 05 March 2014 Pages: 331 - 342

6. Pharmacological Approaches to Reducing Craving in Patients with Alcohol Use Disorders

   • Carolina L. Haass-Koffler
   • Lorenzo Leggio
   • George A. Kenna

   Review Article 27 February 2014 Pages: 343 - 360

   

7. Assessment of the Abuse Liability of a Dual Orexin Receptor Antagonist: A Crossover Study of Almorexant and Zolpidem in Recreational Drug Users

   • Hans G. Cruz
   • Petra Hoever
   • Jasper Dingemanse

   Original Research Article 14 March 2014 Pages: 361 - 372

   

8. Dimethyl Fumarate: A Review of Its Use in Patients with Relapsing-Remitting Multiple Sclerosis

   • Celeste B. Burness
   • Emma D. Deeks

   Adis Drug Evaluation 13 March 2014 Pages: 373 - 387